ZA200701945B - Method of in-vitro detection and quantification of HIV DNA by quantitative PCR - Google Patents
Method of in-vitro detection and quantification of HIV DNA by quantitative PCR Download PDFInfo
- Publication number
- ZA200701945B ZA200701945B ZA200701945A ZA200701945A ZA200701945B ZA 200701945 B ZA200701945 B ZA 200701945B ZA 200701945 A ZA200701945 A ZA 200701945A ZA 200701945 A ZA200701945 A ZA 200701945A ZA 200701945 B ZA200701945 B ZA 200701945B
- Authority
- ZA
- South Africa
- Prior art keywords
- primers
- pair
- seq
- dna
- represented
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 72
- 238000001514 detection method Methods 0.000 title claims abstract description 29
- 238000003753 real-time PCR Methods 0.000 title claims abstract description 18
- 238000000338 in vitro Methods 0.000 title claims abstract description 7
- 238000011002 quantification Methods 0.000 title abstract description 33
- 108020004414 DNA Proteins 0.000 claims abstract description 90
- 241000725303 Human immunodeficiency virus Species 0.000 claims abstract description 59
- 230000003321 amplification Effects 0.000 claims abstract description 43
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 43
- 108020005202 Viral DNA Proteins 0.000 claims abstract description 23
- 108091034117 Oligonucleotide Proteins 0.000 claims abstract description 20
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims abstract description 15
- 108700004026 gag Genes Proteins 0.000 claims abstract description 13
- 101150098622 gag gene Proteins 0.000 claims abstract description 13
- 239000012634 fragment Substances 0.000 claims abstract description 6
- 239000000523 sample Substances 0.000 claims description 33
- 238000012360 testing method Methods 0.000 claims description 20
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 238000002844 melting Methods 0.000 claims description 5
- 230000008018 melting Effects 0.000 claims description 5
- 239000003298 DNA probe Substances 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims description 3
- 239000013615 primer Substances 0.000 claims 20
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims 4
- 239000002751 oligonucleotide probe Substances 0.000 claims 4
- 239000002773 nucleotide Substances 0.000 claims 3
- 125000003729 nucleotide group Chemical group 0.000 claims 3
- 239000003155 DNA primer Substances 0.000 claims 2
- 230000003612 virological effect Effects 0.000 abstract description 18
- 230000035945 sensitivity Effects 0.000 abstract description 6
- 241000700605 Viruses Species 0.000 abstract 1
- 239000000047 product Substances 0.000 description 49
- 210000004027 cell Anatomy 0.000 description 39
- 238000003752 polymerase chain reaction Methods 0.000 description 36
- 208000015181 infectious disease Diseases 0.000 description 10
- 239000013612 plasmid Substances 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 10
- 239000003550 marker Substances 0.000 description 9
- 239000011543 agarose gel Substances 0.000 description 8
- 238000011161 development Methods 0.000 description 8
- 210000004698 lymphocyte Anatomy 0.000 description 8
- 230000001566 pro-viral effect Effects 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000000539 dimer Substances 0.000 description 6
- 230000000798 anti-retroviral effect Effects 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 238000007857 nested PCR Methods 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
- 208000031886 HIV Infections Diseases 0.000 description 4
- 208000037357 HIV infectious disease Diseases 0.000 description 4
- 238000011529 RT qPCR Methods 0.000 description 4
- 238000011225 antiretroviral therapy Methods 0.000 description 4
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 4
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 4
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 4
- 210000000987 immune system Anatomy 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 3
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 3
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 239000003999 initiator Substances 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 108700005077 Viral Genes Proteins 0.000 description 2
- 229940124522 antiretrovirals Drugs 0.000 description 2
- 108091092356 cellular DNA Proteins 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 2
- 241001430294 unidentified retrovirus Species 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101100326581 Caenorhabditis elegans cdh-4 gene Proteins 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000003903 antiretrovirus agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000010485 coping Effects 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 108700004025 env Genes Proteins 0.000 description 1
- 101150030339 env gene Proteins 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002687 intercalation Effects 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- UMFJAHHVKNCGLG-UHFFFAOYSA-N n-Nitrosodimethylamine Chemical compound CN(C)N=O UMFJAHHVKNCGLG-UHFFFAOYSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000004976 peripheral blood cell Anatomy 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000012422 test repetition Methods 0.000 description 1
- 229940021747 therapeutic vaccine Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- AIDS & HIV (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200401986 | 2004-08-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200701945B true ZA200701945B (en) | 2008-07-30 |
Family
ID=35517608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200701945A ZA200701945B (en) | 2004-08-06 | 2007-03-06 | Method of in-vitro detection and quantification of HIV DNA by quantitative PCR |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20090208929A1 (de) |
| EP (1) | EP1711636B1 (de) |
| CN (1) | CN101035911A (de) |
| AT (1) | ATE435304T1 (de) |
| BR (1) | BRPI0514156A (de) |
| CA (1) | CA2573591A1 (de) |
| DE (1) | DE602005015189D1 (de) |
| ES (1) | ES2328944T3 (de) |
| RU (1) | RU2007108303A (de) |
| WO (1) | WO2006013144A2 (de) |
| ZA (1) | ZA200701945B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011078439A1 (en) * | 2009-12-24 | 2011-06-30 | Seegene, Inc. | Real-time multiplexing detection of target nucleic acid sequences with elimination of false signals |
| EP2707496A1 (de) | 2011-05-11 | 2014-03-19 | Diagon Kft. | Verfahren zur schnellen bestimmung von viren mittels nukleinsäurebasierter molekulardiagnostik und kit hierfür |
| WO2015160536A1 (en) * | 2014-04-14 | 2015-10-22 | The United States Of America, As Represented By The Secretary Department Of Health And Human Services | Methods for rapid detection and identification of viral nucleic acids |
| CN109371169B (zh) * | 2018-11-29 | 2022-02-11 | 中国人民解放军军事科学院军事医学研究院 | 一种用于辅助诊断早期hiv感染的试剂盒及其专用成套引物对 |
| CN120758675A (zh) * | 2025-07-04 | 2025-10-10 | 武汉潇正生物科技有限公司 | 快速定量检测整合hiv前病毒基因组的试剂盒及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG63589A1 (en) * | 1993-05-14 | 1999-03-30 | Johnson & Johnson Clin Diag | Diagnostic compositions elements methods and test kits for amplification and detection of two or more dna's using primers having matched melting temperatures |
| US6294326B1 (en) * | 1997-11-07 | 2001-09-25 | Abbott Laboratories | Analyte detection process using dual labeled probes |
| JP2000139500A (ja) * | 1998-11-17 | 2000-05-23 | Tokyoto Igaku Kenkyu Kiko | リアルタイム検出ｐｃｒによるｈｉｖ遺伝子の測定方法並びにそれに用いられるプライマー及びプローブ |
-
2005
- 2005-07-14 BR BRPI0514156-7A patent/BRPI0514156A/pt not_active IP Right Cessation
- 2005-07-14 ES ES05777709T patent/ES2328944T3/es not_active Expired - Lifetime
- 2005-07-14 WO PCT/EP2005/053384 patent/WO2006013144A2/en not_active Ceased
- 2005-07-14 EP EP05777709A patent/EP1711636B1/de not_active Expired - Lifetime
- 2005-07-14 DE DE602005015189T patent/DE602005015189D1/de not_active Expired - Fee Related
- 2005-07-14 CA CA002573591A patent/CA2573591A1/en not_active Abandoned
- 2005-07-14 AT AT05777709T patent/ATE435304T1/de not_active IP Right Cessation
- 2005-07-14 CN CNA2005800339359A patent/CN101035911A/zh active Pending
- 2005-07-14 US US11/632,248 patent/US20090208929A1/en not_active Abandoned
- 2005-07-14 RU RU2007108303/13A patent/RU2007108303A/ru not_active Application Discontinuation
-
2007
- 2007-03-06 ZA ZA200701945A patent/ZA200701945B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0514156A (pt) | 2008-06-03 |
| ATE435304T1 (de) | 2009-07-15 |
| ES2328944T3 (es) | 2009-11-19 |
| WO2006013144A2 (en) | 2006-02-09 |
| RU2007108303A (ru) | 2008-09-20 |
| CA2573591A1 (en) | 2006-02-09 |
| WO2006013144A3 (en) | 2006-06-01 |
| DE602005015189D1 (de) | 2009-08-13 |
| US20090208929A1 (en) | 2009-08-20 |
| EP1711636A2 (de) | 2006-10-18 |
| CN101035911A (zh) | 2007-09-12 |
| EP1711636B1 (de) | 2009-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Curtis et al. | Rapid detection of HIV-1 by reverse-transcription, loop-mediated isothermal amplification (RT-LAMP) | |
| US20040005551A1 (en) | Circulating epstein-barr virus DNA in the serum or plasma of patients for the prediction and detection of epstein-barr virus associated cancers apart from head, neck and lymphoid malignancies | |
| CN108998570B (zh) | 可覆盖多亚型的hiv-1总dna定量检测引物对、探针及检测试剂盒 | |
| CN109196124A (zh) | 同时检测及定量分析四种血源性病毒的多重Taqman探针qPCR的试剂盒及方法 | |
| ZA200701945B (en) | Method of in-vitro detection and quantification of HIV DNA by quantitative PCR | |
| EP3214181B1 (de) | Oligonukleotide, satz von oligonukleotiden, kit zur diagnose und unterscheidung von htlv-i/htlv-ii-infektionen, polynukleotid als referenzziel zum design von primern und sonden zum nachweis und zur differenzierung von htlv-i und htlv-ii, amplicon und verfahren zum nachweis von mindestens einem htlv-ziel | |
| CN103045756A (zh) | 一种荧光定量rt-pcr检测人类免疫缺陷病毒1型的试剂盒 | |
| CN105385684A (zh) | 用于为核酸扩增作对照的寡核苷酸 | |
| Jia et al. | Multiple cross displacement amplification combined with nanoparticle-based lateral flow biosensor for rapid and sensitive detection of Epstein-Barr virus | |
| US6830887B2 (en) | Method and kit for quantitation and nucleic acid sequencing of nucleic acid analytes in a sample | |
| Yeo et al. | Rapid detection of codon 460 mutations in the UL97 gene of ganciclovir-resistant cytomegalovirus clinical isolates by real-time PCR using molecular beacons | |
| CN118240979B (zh) | 一种可视化检测HIV的CRISPR-Cas12a系统以及检测方法 | |
| CN110241264B (zh) | 一种乙型肝炎病毒(hbv)dna定量检测试剂盒 | |
| CN110373503B (zh) | 一种用于以rpa检测汉城病毒的成套核酸、试剂盒以及检测方法 | |
| CN111705164A (zh) | Hiv-1病毒载量实时荧光定量pcr检测特异性引物对、试剂盒 | |
| JP4913042B2 (ja) | Ｈｉｖタイプおよびサブタイプの検出 | |
| CN117821666A (zh) | 用于检测hiv-1的引物组及其应用和检测方法 | |
| Paryan et al. | Design and development of a multiplex real-time PCR assay for detection of HIV-1 and HCV using molecular beacons | |
| WO2021191473A1 (en) | Method and kit for the detection of sars-cov-2 virus in a sample based on reverse transcription loop-mediated isothermal amplification (rt-lamp) | |
| CN114891929B (zh) | 用于检测hiv-1和vb突变株的引物探针组、检测试剂盒及检测方法 | |
| US20240209464A1 (en) | Pathogen Detection From Urine Analyte in All Gender Patients | |
| CN118668015A (zh) | 一种用于猴痘病毒分型检测的组合物、试剂盒及其应用 | |
| Constantine et al. | Molecular-based laboratory testing and monitoring for human immunodeficiency virus infections | |
| US20100291538A1 (en) | Artificial calibration virus to control hiv viral load tests by pcr in real time | |
| CN118127240A (zh) | 检测猴免疫缺陷病毒的引物组及其应用、试剂盒和检测方法 |